Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma

Z Yu1, S Li, Y-Y Huang

  • 1Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Cancer Gene Therapy
|May 26, 2007
PubMed

Insights

Calcium depletion enhances oncolytic herpes simplex virus type 1 (HSV-1) therapy for squamous cell carcinoma (SCC) by increasing nectin-1 receptor expression. This strategy improves viral entry and tumor regression, offering a novel approach to cancer treatment.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Attenuated, oncolytic herpes simplex virus type 1 (HSV-1) show promise in preclinical cancer models.
  • Nectin-1, a receptor for HSV-1 glycoprotein D, is also part of intercellular adherens junctions (AJs).

Purpose of the Study:

  • To investigate if disrupting AJs via calcium depletion can increase nectin-1 exposure and enhance HSV-1 oncolytic therapy in squamous cell carcinoma (SCC).

Main Methods:

  • Utilized calcium depletion in SCC cell lines and murine SCC flank tumors.
  • Administered NV1023, an oncolytic HSV-1, with and without ethylenediaminetetraacetic acid (EDTA).
  • Assessed nectin-1 expression, viral entry, binding, cytotoxicity, and tumor regression.

Main Results:

  • Calcium depletion increased nectin-1 expression and cell separation in SCC cell lines.
  • NV1023 viral entry, soluble gD protein binding, and cytotoxicity were enhanced under low calcium conditions.
  • Combined NV1023 and EDTA treatment significantly improved tumor regression in murine SCC models.

Conclusions:

  • Disrupting adherens junctions by calcium depletion enhances nectin-1 receptor expression on cancer cells.
  • This modulation strategy significantly improves the efficacy of oncolytic HSV-1 therapy.
  • This approach holds potential for enhancing therapies using various herpes vectors.

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...